Comerica Bank’s Prime Medicine PRME Stock Holding History
Bought
Maintained
Sold
Other funds holding PRME
AI
AIM
RG
MM
NAMA
Comerica Bank's PRME Position: Q2 2025 in Review
Comerica Bank sold out of Prime Medicine (PRME) in Q2 2025, closing a stake of 315 shares — an estimated $628 sold.
Comerica Bank first reported a position in PRME in Q3 2023 and held it in 7 quarters. The position peaked at $11.6K in Q4 2023. 121 funds tracked by Wall St. Rank hold PRME as of Q2 2025.
- Comerica Bank reported no remaining Prime Medicine position as of Q2 2025 after selling out during the quarter.
- Comerica Bank sold 315 Prime Medicine shares in Q2 2025, an estimated $628.
- Comerica Bank first reported a position in Prime Medicine in Q3 2023 and held it in 7 quarters.
- Comerica Bank's Prime Medicine position peaked at $11.6K in Q4 2023.
- 121 funds tracked by Wall St. Rank held Prime Medicine as of Q2 2025.
Based on Comerica Bank's 13F filing for Q2 2025, filed 14 Aug 2025.